Drug data last refreshed 3h ago · AI intelligence enriched 6h ago
ADVAIR HFA is a combination inhaler containing fluticasone propionate (inhaled corticosteroid) and salmeterol xinafoate (long-acting beta-2 agonist) delivered via metered-dose aerosol. It is indicated for maintenance treatment of asthma and COPD in patients requiring both anti-inflammatory and bronchodilator therapy. The combination addresses both airway inflammation and bronchoconstriction through dual mechanisms of action.
Brand is in defensive posture with high competitive pressure (30/100); team focus shifting from growth to market share retention and line extension strategies.
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Advair HFA in Healthy and HAPE Predisposed Subjects
Advair HFA For Chronic Obstructive Pulmonary Disease(COPD)
A Study In Pediatric Subjects With Asthma Using ADVAIR HFA, ADVAIR HFA With Spacer, And ADVAIR DISKUS
Worked on ADVAIR HFA at GSK? Share your interview experience or compensation data (+7 days Pro)
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
$398M Medicare spend — this is a commercially significant brand
Working on ADVAIR HFA positions you in a mature, declining-revenue franchise requiring defensive commercial strategy and customer retention excellence. This role emphasizes tactical execution, payer negotiation, and market share preservation rather than growth innovation—valuable for professionals building expertise in LOE management and mature-market dynamics.
Upgrade to Pro to access Medicare Part D spending data and other premium pharma intelligence.
Upgrade to Pro — $25/mo